摘要
Background: @@@ Laryngeal cancer is one of the most common malignant tumors among head and neck cancers. Accumulating studies have indicated that long noncoding RNAs (lncRNAs) play an important role in laryngeal cancer occurrence and progression, however, the functional roles and relative regulatory mechanisms of lncRNA growth arrest-specific transcript 5 (GAS5) in laryngeal cancer progression remain unclear. @@@ Methods: @@@ The expression of lncRNA GAS5 in both laryngeal cancer tissues and cell lines was evaluated using quantitative reverse transcription-polymerase chain reaction (RT-qPCR) assay. The relationships between lncRNA GAS5 expression and clinical parameters were also analyzed. To determine the biological function of lncRNA GAS5, a lncRNA GAS5-specific plasmid was first transfected into laryngeal cancer cells using lentiviral technology. Cell counting kit-8 assay, flow cytometry, and Transwell assays were used to detect in vitro cell proliferation, apoptosis, cycle distribution, and metastasis abilities, respectively. Furthermore, in vivo cell growth experiments were also performed using nude mice. Additionally, western blotting was performed to identify the underlying regulatory mechanism. @@@ Results: @@@ In the current study, lncRNA GAS5 was downregulated in laryngeal cancer tissues and its low expression was closely associated with poor tumor differentiation, advanced TNM stage, lymph node metastasis, and shorter overall survival time. In addition, lncRNA GAS5 upregulation significantly inhibited laryngeal cancer cell proliferation both in vitro and in vivo. Moreover, in response to lncRNA GAS5 overexpression, more laryngeal cancer cells were arrested at the G2/M stage, accompanied by increased cell apoptosis rates and suppressed migration and invasion capacities. Mechanistically, our data showed that the overexpression of lncRNA GAS5 significantly regulated the PI3K/AKT/mTOR signaling pathway. @@@ Conclusion: @@@ LncRNA GAS5 might act as a suppressor gene during laryngeal cancer development, as it suppressed cell proliferation and metastasis by regulating the PI3K/AKT/mTOR signaling pathway; thus, lncRNA GAS5 is a promising therapeutic biomarker for the treatment of laryngeal cancer.
学科与关键词
- Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinomaLili Lan; Huan Cao; Weiwei Chi; Wenxia Meng; Lei Zhao; Weina Cui; Baoshan WangPathology Research and Practice, 2020, 152877.被引 8
- Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell CarcinomaLi, M.; An, J.; Ren, H.; Gui, J.; Wang, H.; Wu, S.; Wu, R.; Xiao, H.*; Wang, L.Bulletin of Experimental Biology and Medicine, 2023.
- HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activationSheng, Xiaoli; Liu, Wenlin; Lu, Zhongming; Xu, Mimi; Li, Rui; Zhong, Rong; Li, Yunxian; Liu, Tao*; Zhang, Siyi*Annals of Translational Medicine, 2021, 9(10): 840.被引 5
